Articles by Rita Peters - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Rita Peters

Employment Outlook: Mixed Results

Dec 1, 2013

The employment picture brightened a bit, but biopharma employees still seek better compensation.

New Funding and Approval Pathways Prove Popular

The JOBS Act and FDASIA show early signs of accelerating drug development.
Nov 1, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.

Filling a Drug Safety Gap

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.
Aug 1, 2013

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.

The Pains of Change

Pharma and biotech companies, with the rest of the healthcare industry, must face change.
Jul 1, 2013

Pharma and biotech companies, with the rest of the healthcare industry, must face change.

Trust in the Pill Bottle

The Ranbaxy settlement provides a cautionary tale for patients, FDA, and drug manufacturers.
Jun 1, 2013

Ranbaxy's $500 million settlement for producing adulterated drugs and fradulent data provides a cautionary tale for patients, FDA, and drug manufacturers.

The Pathway to Publication

Wanted: Aspiring authors to share technical and scientific solutions for biopharmaceutical processing.
May 1, 2013

Wanted: Aspiring authors to share technical and scientific solutions for biopharmaceutical processing.

More than 900 Biologics in Development

Mar 11, 2013

America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report.

Catching Up

A QbD paradigm advances process understanding in development and manufacturing.
Mar 1, 2013

A QbD paradigm advances process understanding in development and manufacturing.

Affymax and Takeda Recall All Lots of OMONTYS (peginesatide) Injection

Feb 25, 2013

Affymax Inc. and Takeda Pharmaceutical Company Limited have decided to voluntarily recall all lots of OMONTYS (peginesatide) Injection to the user level as a result of new postmarketing reports regarding serious hypersensitivity reactions.

ADVERTISEMENT

ADVERTISEMENT

Click here